Packed red blood cells Whereas in high-income countries, most blood transfusions are given to people over 65 years of age (up to 76%). In these countries transfusion are most commonly used for supportive care in heart surgery, transplant surgery, massive trauma, and therapy for solid and blood cancers. Due to changes in surgical practices, medical use of blood is now the major use of red blood cells in high-income countries. Blood transfusion is typically recommended when hemoglobin levels reach 70 g/L (7 g/dL) in those who have stable vital signs. For those with heart disease it is recommended at 80g/L (8 g/dL). RBCs are
Genetically engineered blood Genetically engineered blood Genetically engineered blood is blood that has been modified for therapeutic or other purposes. Genetically modifying red blood stem cells allows them to produce specific therapeutic proteins on the surface or inside the cell. The stem cells are taken from mammalian bone marrow and are modified in culture. Before they become mature, mammalian red blood cells eject their genetic material. Culturing cells that produce a new protein of interest requires only a few weeks. Using the sortagging protein labeling technique, the researchers used the bacterial enzyme sortase A to establish a strong chemical bond between the surface